[{"Assets_0_FY_USD":5848020000.0,"CIK":"1048477","CommonStockSharesConverted_0_FY_shares":181740999.0,"CommonStockSharesOutstanding_0_FY_shares":181740999.0,"Country":"United States","EarningsPerShareBasic_4_FY_USD":4.75,"EarningsPerShareDiluted_4_FY_USD":4.53,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":85365000.0,"NetIncomeLossConverted_4_FY_USD":859100000.0,"OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_4_FY_USD":1860455000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_FY_USD":4106002000.0,"Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":191678000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":180804000.0,"filed":"20210226","footnote":"nan","form":"10-K","fp":"FY","fy":"2020.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20201231","qtrs":"4","uom":"USD"}]